EXTON, Pa., Aug. 23, 2021 /PRNewswire/ -- West
Pharmaceutical Services, Inc. (NYSE: WST), a global leader in
innovative solutions for injectable drug administration, announced
today the Company's Board of Directors has elected Molly
Joseph as its newest member. With the addition of Ms.
Joseph, West's Board has 11 directors.
Ms. Joseph, 47, is the former Chief Executive Officer ("CEO") of
UnitedHealthcare Group, a role she served in for more than a
decade. During her 16-year tenure, she pioneered the establishment
of UnitedHealth Group's global health business into one of the
largest health benefits and medical delivery business outside of
the United States. As CEO of
UnitedHealthcare Global, she had oversight of 55 hospitals and
several hundred ambulatory centers, with over 9 million patients
and 7 million insurance members.
Molly also served UnitedHealth Group in strategy and corporate
development, where she led acquisitions and business transactions.
Prior to joining UnitedHealth Group, she focused on business
transactions as an investment banker and a corporate attorney.
Ms. Joseph serves on the Board of Directors of First Solar and
the Board of Trustees at Santa Clara
University. She is a long-time advisor to Children's
Heartlink, a global nonprofit organization for pediatric cardiac
care and serves on the Board of Directors of Young Voices of
Austin, a nonprofit organization
focused on the advancement of children from diverse
backgrounds.
Ms. Joseph earned her Juris Doctor from Georgetown Law Center
and Bachelor of Science degree from Santa
Clara University.
"We are pleased to welcome Molly
Joseph to West's Board of Directors," said Patrick J. Zenner, Chair of the Board of
Directors, West. "Molly's extensive experience in building and
leading clinically integrated medical delivery systems and health
insurance systems is well-aligned with West's mission and role to
deliver healthcare to millions of patients every day. With her
significant board and industry experience, we know that Molly's
expertise will be a valuable addition to our Board of
Directors."
About West
West Pharmaceutical Services, Inc. is a leading provider of
innovative, high-quality injectable solutions and services. As a
trusted partner to established and emerging drug developers, West
helps ensure the safe, effective containment and delivery of
life-saving and life-enhancing medicines for patients. With almost
10,000 team members across 50 sites worldwide, West helps support
our customers by delivering over 40 billion components and devices
each year.
Headquartered in Exton, Pennsylvania, and in business for nearly a
century, West in its fiscal year 2020 generated over $2.15
billion in sales. West is traded on the New York Stock
Exchange (NYSE: WST) and is included on the Standard
& Poor's 500 index. For more information,
visit https://www.westpharma.com/.
All trademarks and registered trademarks used in this release
are the property of West Pharmaceutical Services, Inc. or its
subsidiaries, in the United States
and other jurisdictions, unless otherwise noted.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/west-elects-new-director-to-the-board-301360702.html
SOURCE West Pharmaceutical Services, Inc.